UK | pharmaphorum

UK

News

NICE says yes to BeiGene's Brukinsa after Scottish nay

BeiGene's BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine NHS use in England and Wales to treat Waldenström macroglobulinaemia (WM

News

UK health leaders warn new PM Liz Truss of crisis-in-waiting

New UK Prime Minister Liz Truss needs to take immediate action to prevent the NHS spiralling out of control this winter, according to groups representing healthcare workers.

News

NICE says no to Lynparza in prostate cancer, creates UK acce...

NICE has said it is unable to recommend NHS use of AstraZeneca's Lynparza for some patients with prostate cancer, after failing to reach an agreement on price with the drugmaker.

News

Great Britain £50 - fifty pounds sterling notes spead out.

UK authority asks for director ban for Alliance Pharma CEO

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director.

News

Mereo fights revolt by largest shareholder Rubric

UK biotech Mereo BioPharma is attempting to face down a revolt by Rubric Capital Management – its largest shareholder holding around 14% of the company – which is agitating for changes to i

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

UK advisors back Moderna's bivalent shot for autumn COVID bo...

The UK's Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna's bivalent COVID-19 vaccine should be used for the autumn booster campaign in adults.

NICE says yes to BeiGene's Brukinsa after Scottish nay

UK health leaders warn new PM Liz Truss of crisis-in-waiting

NICE says no to Lynparza in prostate cancer, creates UK acce...

UK authority asks for director ban for Alliance Pharma CEO

Mereo fights revolt by largest shareholder Rubric

UK advisors back Moderna's bivalent shot for autumn COVID bo...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

UK

Editor's Picks